ArticlePloS one2014

Inhibition of MDM2 by nilotinib contributes to cytotoxicity in both Philadelphia-positive and negative acute lymphoblastic leukemia.

Hailong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.